Intestinal immune-enhancing agent, food product, and medicament
AssigneeDaicel Corporation
InventorsTadashi Takeuchi, Eiji Miyauchi, Shu Shimamoto, Akinobu Matsuyama, Hiroshi Ohno
Life of this patent
Estimating the term…
Abstract
Object of the present invention is to provide an intestinal immune-enhancing agent that can sufficiently increase IgA in the intestinal tract with a low dose while maintaining an increased amount of IgA for an extended period of time. Provided is an intestinal immune-enhancing agent containing a cellulose acetate that has a total degree of acetyl substitution from 0.4 to 1.1.
Claims5
A method for increasing and maintaining of IgA in the intestinal tract of a subject in need thereof, comprising
- intaking by the subject or administering to the subject a cellulose acetate having a total degree of acetyl substitution from 0.4 to 1.1;
- wherein an intake or administration dose per serving is from 5 mg/kg body weight to 60 mg/kg body weight.
A method for treating infections caused by pathogenic bacteria belonging to the phylum Proteobacteria in a subject, where the pathogenic bacteria are Salmonella, cholera, or Vibrio parahaemolyticus,
- the method comprising
- intaking by the subject or administering to the subject a cellulose acetate having a total degree of acetyl substitution from 0.4 to 1.1;
- wherein an intake or administration dose per serving is from 5 mg/kg body weight to 60 mg/kg body weight.
A method for increasing and maintaining of IgA in the intestinal tract of a subject infected with pathogenic bacteria belonging to the phylum Proteobacteria, comprising
- intaking by the subject or administering to the subject a water-soluble dietary fiber selected from a cellulose acetate having a total degree of acetyl substitution from 0.4 to 1.1;
- wherein an intake or administration dose per serving is from 5 mg/kg body weight to 60 mg/kg body weight.
Dependencies are inferred from the claim text.